NCT01880151View on ClinicalTrials.gov

Neuroelectrical Biomarkers for Alzheimer's Disease Stages

NACompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

July 12, 2013

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Alzheimer Disease
Interventions
DEVICE

EEG

EEG recorded during a resting condition and during an episodic memory task condition

Trial Locations (1)

75013

Institute of Memory and Alzheimer's Disease, Pitie-Salpetriere Hospital, Paris

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT01880151 - Neuroelectrical Biomarkers for Alzheimer's Disease Stages | Biotech Hunter | Biotech Hunter